Sunday - May 20, 2012
FAQ's     |     Privacy Policy     |     Site Map
 

Mission Statement:

Cardiovascular Associates Research Foundation is a non-profit foundation dedicated to research in the treatment of cardiovascular and peripheral vascular disease.

Through participation in research protocols the physicians have the opportunity to provide their patients with new treatment options through procedural technology, pharmaceutical therapy and disease monitoring that may otherwise not be available.

 

Our Vision:

To provide the most advanced high quality cutting edge research opportunities to benefit the current cardiovascular and peripheral vascular patients and for the patients that will benefit in the future.

 
 
 
 
The Choice Trial: Carotid Stenting for high surgical risk patients. Dr. Sarah Johnson and Dr. Jack Chamberlin
 
 
 
The Sapphire Trial: Stenting and angioplasty for patients with high risk for endarterectomy Dr Jack Chamberlin and Dr. Sarah Johnson
 
 
 
The Assert Trial: Pacemaker Dr. John Kall, Dr. Hemal Nayak and Dr. Mohammed Khan
 
 
 
The Response Trial: Cardiac resynchronization in heart failure patients Dr. Mohammed khan, Dr. Hemal Nayak and Dr. John Kall
 
 
 
The Premium Trial: Evaluation of PFO closures if effective in reducing disabling migraine headaches. Dr. Sarah Johnson
 
 
 
The Ascend; Heart Failure Trial; Dr. Martin Mullen and Dr. John Furiasse
 
 
 
The Topcat Trial; Heart Failure Trial Dr. John Furiasse, Dr. Martin Mullen and Dr. Eric Burseth
 
 
 
The Red Trial: Heart Failure Dr. Martin Mullen, Dr. John Furiasse, Dr. Eric Burseth and Dr. Scott Tomasik